Sarah Cole, Takeda Ventures partner

Al­most a decade af­ter iden­ti­fy­ing a new class of RNA, a group of sci­en­tists sparks in­ter­est from Take­da Ven­tures

Over the last sev­er­al years, sci­en­tists have turned their at­ten­tion to long non­cod­ing RNAs (lncR­NAs) — a mys­te­ri­ous class of nat­u­ral­ly oc­cur­ring mol­e­cules that don’t code for pro­teins, but ful­fill im­por­tant reg­u­la­to­ry func­tions in the cell. Ste­fano Gustin­ci­ch and his team iden­ti­fied a new class of them back in 2012, and now the sci­en­tists have pulled in seed fund­ing to see if the mol­e­cules can go where cur­rent ther­a­peu­tics can’t.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.